Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-04-24 09:27 am Sale |
2025-03-31 | 13G | Gilead Sciences, Inc. GILD |
BlackRock Inc. BLK |
101,739,273 8.200% |
-21,051,024 (-17.14%) |
Filing History |
| 2025-03-20 4:32 pm Purchase |
2025-03-18 | 13G | AlloVir, Inc. ALVR |
GILEAD SCIENCES INC. GILD |
723,273 3.900% |
723,273 (New Position) |
Filing History |
| 2025-03-05 5:00 pm Unchanged |
2025-02-18 | 13D | Arcus Biosciences, Inc. RCUS |
GILEAD SCIENCES INC. GILD |
39,691,649 35.000% |
0 (Unchanged) |
Filing History |
| 2025-02-20 7:43 pm Purchase |
2025-02-18 | 13D | Arcus Biosciences, Inc. RCUS |
GILEAD SCIENCES INC. GILD |
39,691,649 35.000% |
8,158,868 (+25.87%) |
Filing History |
| 2025-02-13 4:22 pm Sale |
2024-12-31 | 13G | Ikena Oncology, Inc. IKNA |
GILEAD SCIENCES INC. GILD |
1,521,312 3.600% |
-1,410,155 (-48.10%) |
Filing History |
| 2025-01-10 3:46 pm Unchanged |
2025-01-07 | 13D | Galapagos NV GLPG |
GILEAD SCIENCES INC. GILD |
20,981,010 29.900% |
0 (Unchanged) |
Filing History |
| 2024-12-23 8:17 pm Purchase |
2024-12-19 | 13D | Assembly Biosciences, Inc. ASMB |
GILEAD SCIENCES INC. GILD |
2,209,471 29.900% |
940,499 (+74.12%) |
Filing History |
| 2024-12-19 4:15 pm Purchase |
2024-12-18 | 13G | Xilio Therapeutics, Inc. XLO |
GILEAD SCIENCES INC. GILD |
9,105,451 19.900% |
1,759,978 (+23.96%) |
Filing History |
| 2024-06-20 8:35 pm Purchase |
2024-06-17 | 13D | Assembly Biosciences, Inc. ASMB |
GILEAD SCIENCES INC. GILD |
1,268,972 19.990% |
179,500 (+16.48%) |
Filing History |
| 2024-05-02 9:29 pm Purchase |
2024-04-30 | 13D | Galapagos NV GLPG |
GILEAD SCIENCES INC. GILD |
20,981,010 29.900% |
352,081 (+1.71%) |
Filing History |
| 2024-04-19 4:31 pm Purchase |
2024-04-10 | 13G | Leap Therapeutics, Inc. LPTX |
GILEAD SCIENCES INC. GILD |
5,319,148 13.900% |
5,319,148 (New Position) |
Filing History |
| 2024-04-05 4:31 pm Purchase |
2024-03-27 | 13G | Xilio Therapeutics, Inc. XLO |
GILEAD SCIENCES INC. GILD |
7,345,473 19.900% |
7,345,473 (New Position) |
Filing History |
| 2024-02-20 4:31 pm Purchase |
2024-02-12 | 13G | Kyverna Therapeutics, Inc. KYTX |
GILEAD SCIENCES INC. GILD |
4,126,119 9.600% |
4,126,119 (New Position) |
Filing History |
| 2024-02-13 5:06 pm Sale |
2023-12-29 | 13G | Gilead Sciences, Inc. GILD |
The Vanguard Group | 111,820,711 8.970% |
-217,613 (-0.19%) |
Filing History |
| 2024-02-13 4:54 pm Purchase |
2023-12-31 | 13G | AlloVir, Inc. ALVR |
GILEAD SCIENCES INC. GILD |
723,273 14.600% |
127,429 (+21.39%) |
Filing History |
| 2024-02-13 4:51 pm Unchanged |
2023-12-31 | 13G | Tango Therapeutics, Inc. TNGX |
GILEAD SCIENCES INC. GILD |
4,854,443 4.800% |
0 (Unchanged) |
Filing History |
| 2024-02-09 6:21 pm Purchase |
2024-02-07 | 13G | Gilead Sciences, Inc. GILD |
Capital World Investors | 83,698,215 6.700% |
14,797,217 (+21.48%) |
Filing History |
| 2024-01-31 4:58 pm Purchase |
2024-01-29 | 13D | Arcus Biosciences, Inc. RCUS |
GILEAD SCIENCES INC. GILD |
31,532,781 35.000% |
5,945,828 (+23.24%) |
Filing History |
| 2024-01-24 2:27 pm Sale |
2023-12-31 | 13G | Gilead Sciences, Inc. GILD |
BlackRock Inc. BLK |
122,790,297 9.900% |
-8,765,472 (-6.66%) |
Filing History |
| 2023-12-28 5:06 pm Purchase |
2023-12-28 | 13G | Arcellx, Inc. ACLX |
GILEAD SCIENCES INC. GILD |
6,720,803 12.900% |
3,242,542 (+93.22%) |
Filing History |